Schering Aktiengesellschaft

Other

Schering Aktiengesellchaft

Scharing Aktiengesellschaft

Dieter Heldmann

Thomas Fritzsch

Joachim Siegert

Werner Weitschies

Ulrich Speck

Ludger Dinkelborg

Friedhelm Blume

Georg Roessling

Michael Stein

Peter Hauff

Stephan Hilger

Harald Stahl

Johannes Platzek

Ulrich Niedballa

Christoph-Stephan Hilger

Kai Licha

Michael Reinhardt

Bj&ouml;rn Riefke

Heidemarie Goerner

Dietmar Berndorff

Violetta Sudmann

Werner Weitschiess

Heribert Miklautz

Gunnar Tepe

Bernhard Noll

Stephan Duda

The invention relates to radioactive stents, characterized in that the stent is coated on the surface with the radioactive isotope, as well as processes for their production.

Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxis

New chelating agents as well as their tricarbonyl complexes with technetium and rhenium and the use of these compounds in radiodiagnosis and radiotherapy are described. The new chelating agents are coupled to substances that accumulate in the diseased tissue.

Chelating agents as well as their tricarbonyl complexes with technetium and rhenium

The invention relates to a process for therapeutic treatment of proliferative diseases, which is characterized in that first an administration catheter is placed on the site of the lesion, and a radioactive substance is administered topically via the catheter, then the catheter is again removed, and the radioactive substance remains on the site of the lesion.

Process for therapeutic treatment of proliferative diseases

The invention relates to microparticle preparations made of biodegradable copolymers for use in treatment and diagnosis, especially ultrasonic diagnosis, as well as a process for their production.

Microparticle preparations made of biodegradable copolymers

This invention relates to colloidal systems charged with polymethine dyes and having suitable photophysical and pharmacological properties, their use as a contrast medium in fluorescence and transillumination diagnostics in the near infrared spectral range, as well as methods for their production.

Contrast medium for near infrared diagnosis

Compositions containing microparticles having at least one surface-active substance and at least one non-surface-active solid with a gaseous component containing a halogenated hydrocarbon that is gaseous at body temperature, wherein the gaseous component is more poorly water-soluble than air. Also, ultrasonic contrast media containing such composition, processes for their production, kits for their production and methods of use.

Microparticles that contain gas, galactose and a saturated fatty acid

The invention relates to new microparticles containing active ingredients, which contain at least one gas or a gaseous phase in addition to the active ingredient(s), agents containing these particles (microparticulate systems), their use for ultrasound-controlled in vivo release of active ingredients, as well as a process for the production of particles and agents.

Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production

The invention relates to ultrasonic contrast agents consisting of microparticles which consist of amyloses and synthetic biodegradable polymers and a gas and/or a fluid with a boiling point below 60&deg; C., process for the preparation thereof and their use as diagnostic and therapeutic agents.

Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent

The invention relates to ultrasonic contrast agents comprising microparticles which comprise synthetic biodegradable polymers and a gas and/or a fluid with a boiling point below 60&deg; C., processes for the preparation thereof and their use as diagnostic and therapeutic agents.

Agents and methods for enhancing contrast in ultrasound imaging

The invention relates to ultrasonic contrast agents comprising microparticles which comprise synthetic biodegradable polymer which is a polyalkylcyanoarylate and a gas and/or a fluid with a boiling point below 60.degree. C., processes for the preparation thereof and their use as diagnostic and therapeutic agents.

Polyalkylcyanoacrylate agents and methods for enhancing contrast in

Microparticles containing active ingredients, agents containing these

The invention relates to a method for obtaining an ultrasonic image of a patient with ultrasonic color Doppler modality with microparticulate ultrasonic contrast agents in regions where the ultrasonic contrast agents are essentially motionless.

Growing community of inventors

Berlin, Germany

Dieter Heldmann